World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

SJIF Impact Factor: 7.533

Abstract

A COMPARATIVE CLINICAL STUDY OF VASA AVALEHA AND KANTAKARI AVALEHA IN THE MANAGEMENT OF PEDIATRIC KAPHAJA KASA

Dr. Bhargav Mehta*, Vd. Manchak Kendre, Dr. Nagesh Gandagi

ABSTRACT

Background: Kaphaja Kasa (productive cough) is a common respiratory ailment in children, often linked to dietary and environmental triggers that vitiate Kapha Dosha. In Ayurveda, Avaleha are preferred for their palatability and sustained action. Aims: This study compares the clinical efficacy of Vasa Avaleha and Kantakari Avaleha in school-aged children (6-16 years). Methods: A randomized comparative clinical trial was conducted with 100 patients divided into Group A (Kantakari Avaleha) and Group B (Vasa Avaleha). Parameters including Total Leukocyte Count (TC), ESR, and cough frequency were assessed over 14 days. Results: Both groups showed significant improvement; however, Group A exhibited a superior reduction in TC levels (Mean Diff: 1045.5 cells/mm³) and a higher percentage of "Good" to "Excellent" clinical outcomes (83.8%) compared to Group B. Conclusion: Kantakari Avaleha is highly effective in managing pediatric Kaphaja Kasa by breaking the pathogenesis (Samprapti Vighatana) through its bronchodilatory and Chedana (expectorant) properties.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR